ASX Announcements

Quarterly report and cash flow statement for Q3 2020
Neuren requests Orphan designations for NNZ-2591 in Europe
Neuren initiates manufacture of NNZ-2591 for Phase 2 trials
Half-year Shareholder Update
Half Yearly Report and Accounts
Corporate presentation, 18 August 2020
Change of Director's Interest Notice
Appendix 2A
Change of Director's Interest Notice
Completion of Share Purchase Plan

Pages:
1 2 3 4 5 6 7 8 9 10 ... Next